CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION

Certain information on this webpage contains or incorporates comments that constitute forward-looking information within the meaning of applicable securities legislation ("forward-looking information"). Forward-looking information, in general, can be identified by the use of forward-looking terminology such as "may", "will", "could", "would", "might", "expect", "intend", "estimate", "anticipate", "believe", "plan", "continue", "budget", "schedule", or "forecast" or similar expressions suggesting future outcomes or events. They include, but are not limited to, statements with respect to expectations, forecasts or other characterizations of future events or circumstances, and Organigram's objectives, goals, strategies, beliefs, intentions, plans, estimates, projections and outlook, including statements relating to Organigram's plans and objectives, or estimates or predictions of actions of customers, suppliers, partners, distributors, competitors or regulatory authorities; and statements regarding Organigram's future economic performance.

These statements are not historical facts but instead represent management's beliefs regarding future events, many of which by their nature are inherently uncertain and beyond management's control. Forward-looking information on this webpage is based on Organigram's current expectations about future events.

Certain forward-looking information on this webpage includes, but is not limited to:

​

• Expectations regarding European Union Good Manufacturing Practice ("EU-GMP") certification;

• Organigam's plans for expansion into international markets; 

• The commercialization of FAST™ (Fast Acting Soluble Technology) nanoemulsion technology and the competitive edge in the gummy category with this technology;

• Expectations regarding the prospects for Organigram's primary operating subsidiaries; 

• Expectations regarding the prospects of Organigram's collaboration and investment transaction with a wholly-owned subsidiary of British American Tobacco p.l.c.; 

• Expectations regarding production capacity, facility size, tetrahydrocannabinol ("THC") content, costs and yields; 

• Strategic investments and capital expenditures, and expected related benefits; 

• Expectations regarding the Company's investments in Weekend Holdings Corp ("WHC"), the parent company of Green Tank Technologies Corp. ("Greentank"), Steady State LLC (d/b/a Open Book Extracts) ("OBX"), and Sanity Group GmbH ("Sanity Group");

• Expectations regarding the Company's acquisition and integration of Collective Project Limited ("CPL");

• Expectations regarding the Company's acquisition, integration and synergy realization of Motif and CPL;

• Expectations concerning the Company's financial position, future liquidity and other financial results;

• The ability of the Company to generate cash flow from operations and from financing activities;

• The competitive conditions of the industry, including the Company’s ability to maintain or grow its market share; and

• Expectations regarding the Company's ability to generate cost savings from operational effectiveness, integration and automation initiatives.

Forward-looking information is provided for the purposes of assisting you in understanding Organigram and its business, operations, risks, financial performance, financial position and cash flows as at and for periods ended on certain dates, and to present information about management's current expectations and plans relating to the future. You are cautioned that such statements may not be appropriate for other purposes. In addition, this webpage may contain forward-looking information attributed to third party industry sources. Undue reliance should not be placed on forward-looking information, as there can be no assurance that the plans, intentions or expectations upon which they are based will occur. Forward-looking information does not guarantee future performance and involves known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in the forward-looking information.

By its nature, forward-looking information involves numerous assumptions, known and unknown risks and uncertainties, both general and specific, that contribute to the possibility that the expectations, predictions, forecasts, projections and conclusions will not occur or prove accurate, that assumptions may not be correct, and that objectives, strategic goals and priorities will not be achieved. These and other factors may cause actual results or events to differ materially from those anticipated in the forward-looking information.

Factors that could cause actual results to differ materially from those set forth in forward-looking information include, but are not limited to: financial risks; cyber security risks; dependence on senior management and other key personnel, the board of directors of Organigram (the "Board of Directors"), consultants and advisors; availability and sufficiency of insurance including continued availability and sufficiency of director and officer and other forms of insurance; Organigram and its subsidiaries being able to, where applicable, cultivate cannabis pursuant to applicable law and on the currently anticipated timelines and in anticipated volumes; industry competition; global events, including heightened economic and industry uncertainty as a result of international trade disputes sparked by tariffs and retaliatory tariffs or other non-tariff measures or any pandemic or epidemic and governmental action in respect thereto, including with respect to impacts on production, operations, disclosure controls and procedures or internal control over financial reporting, and supply chain and distribution disruptions; facility and technological risks; changes to government laws, regulations or policies, including customs, tariffs, trade, environmental or tax, or the enforcement thereof; agricultural risks; ability to maintain any required licenses or certifications; supply risks; product risks; construction delays or postponements; packaging and shipping logistics; inflationary risk, expected number of medical and recreational cannabis users in Canada and internationally; continuation of shipments to existing and prospective international jurisdictions and customers; potential time frame for the implementation of legislation to legalize cannabis internationally; Organigram’s and its investees’ ability to, where applicable, obtain and/or maintain their status as licensed producers (a "Licensed Producer" or "LP") or other applicable licensees; risk factors affecting its investees; availability of any required financing on commercially acceptable terms or at all; the potential size of the regulated recreational cannabis market in Canada; demand for and changes in Organigram's cannabis and related products, including Organigram's derivative products, and the sufficiency of the retail networks to supply such demand; ability of Organigram to develop current and future vapour hardware; ability to enter and participate in international market opportunities; general economic, financial market, regulatory, industry and political conditions affecting Organigram; the ability of Organigram to compete in the cannabis industry and changes in the competitive landscape; a material decline in cannabis prices; the Company’s ability to manage anticipated and unanticipated costs; Organigram’s ability to implement and maintain effective internal control over financial reporting and disclosure controls and procedures; risks relating to potential failure of Organigram's information technology ("IT") system; the effectiveness of Organigram's enterprise resource planning ("ERP") system; continuing to meet listing standards for the TSX and the NASDAQ; risks relating to Organigram's IP; liquidity risk; concentration risk; and other risks and factors described from time to time in the documents filed by Organigram with securities regulators in Canada and the U.S. Material factors and assumptions used in establishing forward-looking information include that production activities will proceed as planned, and demand for cannabis and related products will change in the manner expected by management. All forward-looking information on this webpage is provided as of May 29, 2025.

 
Organigram does not undertake to update any such forward-looking information whether as a result of new information, future events or otherwise, except as required by law.

ADDITIONAL INFORMATION ABOUT THE ASSUMPTIONS, RISKS AND UNCERTAINTIES OF ORGANIGRAM'S BUSINESS AND MATERIAL FACTORS OR ASSUMPTIONS ON WHICH INFORMATION CONTAINED IN FORWARD-LOOKING INFORMATION IS BASED IS PROVIDED IN ORGANIGRAM'S DISCLOSURE MATERIALS, INCLUDING IN ORGANIGRAM'S MOST RECENTLY FILED MANAGEMETN'S DISCUSSION & ANALYSIS UNDER "RISK FACTORS" AND ORGANIGRAM'S CURRNT ANNUAL INFORMATION FORM UNDER "RISK FACTORS", FILED WITH THE SECURITIES REGULATORY AUTHORITIES IN CANADA AND AVAILABLE UNDER ORGANIGRAM'S ISSUER PROFILE ON SEDAR+ AT WWW.SEDARPLUS.CA, AND FILED WITH OR FURNISHED TO THE SEC AND AVAILABLE ON EDGAR AT WWW.SEC.GOV. ALL FORWARD-LOOKING INFORMATION ON THIS WEBPAGE IS QUALIFIED BY THESE CAUTIONARY STATEMENTS.